Omar Al-Salihi

Omar Al-Salihi, Clinical oncology consultant

Clinical oncology consultant


Omar Al-Salihi joined Guy's and St Thomas' in March 2018, having previously been a consultant at University Hospital Southampton for 10 years, specialising primarily in radiotherapy for paediatric and TYA patients with cancer, in addition to treating adult brain tumours.

One of his priorities was enabling access for adult and paediatric patient to trials. He was principal investigator to several studies including CATNON, HCQ, ROAM, PARADIGM, IMRiS and IMA950 (a first in man phase 1 trial of a peptide vaccine in glioblastoma patients).

At Guy’s Cancer Centre and King’s College Hospital (KCH), he works as part of a highly dedicated team of professionals delivering world class oncology care for patients with malignant and benign brain tumours.

Education and training

  • BSc Neuroscience 1994- UMDS (Guy’s and St. Thomas’)
  • MBBS 1997- UMDS (Guy’s and St. Thomas’)
  • MRCP UK-2000
  • FRCR -2004
  • CCST-2006

Research interests

  • re-irradiation in glioblastoma (PI for Brioche trial)
  • ongoing analysis of outcome data for patients in our SRS service receiving treatment for brain metastases
  • analysis of radio-necrosis in patients with meningiomas receiving SRS
  • the application of MRI tractography in the treatment of patients with brain metastases


Royal College of Radiologists Cyclotron Trust Visiting Fellowship, awarded in 2014.

Last updated: May 2022

Is this page useful?